Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

FABIO FULFARO

Association of immune-regulatory (FoxP3+)-T-cell tumor infiltration status with benefit from chemoimmunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients.

  • Authors: Correale, P; Tagliaferri, P; Del Vecchio, MT; Remondo, C; Migali, C; Tsang, KY; Rotundo, MS; Fulfaro, F; Tassone, P; Francini, G
  • Publication year: 2009
  • Type: eedings
  • Key words: cancer, chemoimmunotherapy, colon
  • OA Link: http://hdl.handle.net/10447/44442